Childhood cancer survivors may have impaired health-related quality of life. Proton radiotherapy might improve outcomes among childhood cancer survivors. We report mature health-related quality of life of children, adolescent and young adult patients treated with proton radiotherapy using both child self- and parent-proxy report PedsQL 4.0 Generic Core Scales at baseline and annually thereafter, as well as associations between patient characteristics, toxicity and health-related quality of life scores at follow-up.

Short bio:

Dora Correia is a Portuguese physician-scientist and a Swiss board-certified radiation oncologist. Before graduating from Medical School with a master’s degree at the University of Coimbra, Portugal, she has gathered clinical/research exchange experience in Germany and  Japan. After working as a resident in Portugal, at the University Hospital of Zürich, and the Paul-Scherrer Institute, Dora completed the Radiation Oncology residency (as chief resident) and Swiss doctorate at the University Hospital of Bern, where she practiced mainly in the CNS and radiosurgery/SBRT team. For now almost a year, Dora is working with Dr. Torunn Yock as a pediatric proton therapy research fellow, mostly in the Pediatric Proton/Photon Consortium Registry, under the Swiss Cancer Research Foundation's sponsorship.

Dora received the 2020 International Society of Pediatric Oncology Young Investigator award with the study which will be presented today.

Moreover, as the MGH Postdoc Association Social Networking subcommittee chair, she invites all MGH graduates and postdocs to attend the monthly Social Connection virtual event, on the last Thursday of the month.